相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab Support for Osteoblastic Differentiation
Darcy A. Kerr et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas
Francesca Gianno et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis
Ramses G. Forsyth et al.
CANCERS (2021)
Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology
Mathilde Treffel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists
Muhammad Usman Tariq et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone
Nasir Ud Din et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2020)
Excess of second tumors in denosumab-treated patients: a metabolic hypothesis
Valeria Tovazzi et al.
FUTURE ONCOLOGY (2019)
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2019)
Immunohistochemistry for Histone H3G34W and H3K36M Is Highly Specific for Giant Cell Tumor of Bone and Chondroblastoma, Respectively, in FNA and Core Needle Biopsy
Inga-Marie Schaefer et al.
CANCER CYTOPATHOLOGY (2018)
Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses
Ikuma Kato et al.
HISTOPATHOLOGY (2018)
Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone
Hidetaka Yamamoto et al.
HUMAN PATHOLOGY (2018)
Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR)
Gabriella Gamberi et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India
Bharat Rekhi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E. Palmerini et al.
EUROPEAN JOURNAL OF CANCER (2017)
H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant
Julian Lueke et al.
HISTOPATHOLOGY (2017)
Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls
Pablo Daniel Roitman et al.
HUMAN PATHOLOGY (2017)
How safe and effective is denosumab for bone giant cell tumour?
Costantino Errani et al.
INTERNATIONAL ORTHOPAEDICS (2017)
Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab
Shinji Tsukamoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
Fernanda Amary et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series
Ilaria Girolami et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone
Frank Traub et al.
EUROPEAN JOURNAL OF CANCER (2016)
Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature
Andrea Sanchez-Pareja et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2016)
MORPHOLOGIC EVALUATION OF THE EFFECT OF DENOSUMAB ON GIANT CELL TUMORS OF BONE AND A NEW GRADING SCHEME
Kivilcim Eren Erdogan et al.
POLISH JOURNAL OF PATHOLOGY (2016)
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
Aneta Borkowska et al.
ONCOLOGY LETTERS (2016)
Neoadjuvant denosumab for extensive giant cell tumor in os ischium - a case report
Lizz Van Der Heijden et al.
ACTA ORTHOPAEDICA (2015)
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma
Arjen H. G. Cleven et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab
Luis A. Aponte-Tinao et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone
John Wojcik et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Sam Behjati et al.
NATURE GENETICS (2013)
Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel G. Branstetter et al.
CLINICAL CANCER RESEARCH (2012)
Smooth muscle actin expression in primary bone tumours
F. Hemingway et al.
VIRCHOWS ARCHIV (2012)
The immunophenotype of osteoclasts and macrophage polykaryons
F. Maggiani et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
CD33+CD14-Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone
Ramses G. Forsyth et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms
Gitte De Boeck et al.
JOURNAL OF PATHOLOGY (2009)
Telomere biology in giant cell tumour of bone
R. G. Forsyth et al.
JOURNAL OF PATHOLOGY (2008)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
